Harvest Portfolios Group Inc. Has $1.03 Million Stock Holdings in Healthpeak Properties, Inc. $DOC

Harvest Portfolios Group Inc. lessened its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 31.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 64,328 shares of the real estate investment trust’s stock after selling 29,496 shares during the quarter. Harvest Portfolios Group Inc.’s holdings in Healthpeak Properties were worth $1,034,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the company. State Street Corp lifted its stake in shares of Healthpeak Properties by 1.8% during the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after acquiring an additional 895,460 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of Healthpeak Properties by 41.0% during the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after acquiring an additional 8,212,504 shares during the period. Cullen Capital Management LLC lifted its stake in shares of Healthpeak Properties by 6.7% during the third quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock valued at $195,960,000 after acquiring an additional 641,771 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Healthpeak Properties by 4.1% during the third quarter. Dimensional Fund Advisors LP now owns 10,228,560 shares of the real estate investment trust’s stock valued at $195,873,000 after acquiring an additional 400,900 shares during the period. Finally, Bank of America Corp DE lifted its stake in shares of Healthpeak Properties by 28.5% during the third quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock valued at $190,292,000 after acquiring an additional 2,206,222 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on DOC shares. Robert W. Baird upped their price target on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Evercore downgraded Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price objective for the company. in a report on Monday, May 11th. Argus downgraded Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Citigroup upped their price objective on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a report on Tuesday, May 12th. Finally, Royal Bank Of Canada upped their price objective on Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a report on Thursday, May 14th. Five investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $18.92.

Healthpeak Properties Trading Up 2.0%

NYSE DOC opened at $19.70 on Thursday. The stock has a 50-day simple moving average of $17.39 and a 200 day simple moving average of $17.23. The company has a market capitalization of $13.58 billion, a PE ratio of 61.55, a P/E/G ratio of 2.45 and a beta of 1.00. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties, Inc. has a 12 month low of $15.70 and a 12 month high of $19.91.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. The business had revenue of $752.95 million during the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm’s revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Research analysts forecast that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, June 26th. Stockholders of record on Monday, June 15th will be given a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) dividend on an annualized basis and a dividend yield of 6.2%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 381.25%.

Insider Activity at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.23% of the stock is currently owned by corporate insiders.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.